keyword
https://read.qxmd.com/read/38705934/consensus-commentary-and-position-of-the-italian-society-of-nephrology-on-kdigo-controversies-conference-on-novel-anemia-therapies-in-chronic-kidney-disease
#21
JOURNAL ARTICLE
Francesco Locatelli, Lucia Del Vecchio, Ciro Esposito, Loreto Gesualdo, Giuseppe Grandaliano, Maura Ravera, Roberto Minutolo
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are new drugs developed for the treatment of anemia associated with chronic kidney disease (CKD). This class of drugs stimulates endogenous erythropoietin production and, at the same time, improves iron absorption and mobilization of iron stores (less evident with daprodustat, vadadustat and enarodustat). Several studies have been published in the last few years showing that these agents are not inferior to standard therapy in correcting anemia associated with CKD...
May 6, 2024: Journal of Nephrology
https://read.qxmd.com/read/38704807/regulatory-effect-of-yinchenhao-decoction-on-bile-acid-metabolism-to-improve-the-inflammatory-microenvironment-of-hepatocellular-carcinoma-in-mice
#22
JOURNAL ARTICLE
Jian Shi, Lin Zhu, Bang-Yi Tang, Wan-Qing Yang, Sheng-Yan Xi, Chen-Long Zhang, Peng-Fei Li, Yu-Jie Wang, Kai-Hang Guo, Jing-Ru Huang, Chen-Rui Huang, Zhou-Xin Yu, Bao-Kang Yu, Chun-Fang Zhang, Yu-Mei Zhang
Hepatocellular carcinoma (HCC) is a malignant tumor with extremely high mortality. The tumor microenvironment is the "soil" of its occurrence and development, and the inflammatory microenvironment is an important part of the "soil". Bile acid is closely related to the occurrence of HCC. Bile acid metabolism disorder is not only directly involved in the occurrence and development of HCC but also affects the inflammatory microenvironment of HCC. Yinchenhao decoction, a traditional Chinese medicine formula, can regulate bile acid metabolism and may affect the inflammatory microenvironment of HCC...
May 5, 2024: Journal of Natural Medicines
https://read.qxmd.com/read/38704208/contemporary-trends-and-outcomes-after-liver-transplantation-and-resection-for-intrahepatic-cholangiocarcinoma
#23
JOURNAL ARTICLE
Thomas Clark Howell, Kristen E Rhodin, Brian Shaw, Jiayin Bao, Elishama Kanu, Sabran Masoud, Alex J Bartholomew, Qimeng Gao, Imran J Anwar, Joseph M Ladowski, Daniel P Nussbaum, Dan G Blazer, Sabino Zani, Peter J Allen, Andrew S Barbas, Michael E Lidsky
BACKGROUND: Liver transplantation (LT) has been shown to be superior to resection in highly selected patients with perihilar cholangiocarcinoma (CCA), yet has traditionally been contraindicated for intrahepatic CCA (iCCA). Herein, we aimed to examine contemporary trends and outcomes for surgical resection and LT for iCCA. METHODS: The National Cancer Database was queried for patients presenting with stage I-III iCCA between 2010 and 2018 who underwent resection or LT...
May 2024: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38704134/activation-of-ppar%C3%AE-in-bone-marrow-endothelial-progenitor-cells-improves-their-hematopoiesis-supporting-ability-after-myelosuppressive-injury
#24
JOURNAL ARTICLE
Mi Liang, Zhong-Shi Lyu, Yuan-Yuan Zhang, Shu-Qian Tang, Tong Xing, Yu-Hong Chen, Yu Wang, Qian Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yuan Kong
Dysfunctional bone marrow (BM) endothelial progenitor cells (EPCs) with high levels of reactive oxygen species (ROS) are responsible for defective hematopoiesis in poor graft function (PGF) patients with acute leukemia or myelodysplastic neoplasms post-allotransplant. However, the underlying mechanism by which BM EPCs regulate their intracellular ROS levels and the capacity to support hematopoiesis have not been well clarified. Herein, we demonstrated decreased levels of peroxisome proliferator-activated receptor delta (PPARδ), a lipid-activated nuclear receptor, in BM EPCs of PGF patients compared with those with good graft function (GGF)...
May 2, 2024: Cancer Letters
https://read.qxmd.com/read/38703929/mitochondrial-transplantation-a-promising-therapy-for-mitochondrial-disorders
#25
REVIEW
Qiangqiang Jiao, Li Xiang, Yuping Chen
As a vital energy source for cellular metabolism and tissue survival, the mitochondrion can undergo morphological or positional change and even shuttle between cells in response to various stimuli and energy demands. Multiple human diseases are originated from mitochondrial dysfunction, but the curative succusses by traditional treatments are limited. Mitochondrial transplantation therapy (MTT) is an innovative therapeutic approach that is to deliver the healthy mitochondria either derived from normal cells or reassembled through synthetic biology into the cells and tissues suffering from mitochondrial damages and finally replace their defective mitochondria and restore their function...
May 2, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38703552/analysis-of-anti-tumor-effect-and-mechanism-of-gls1-inhibitor-cb-839-in-colorectal-cancer-using-a-stroma-abundant-tumor-model
#26
JOURNAL ARTICLE
Ryo Miyamoto, Hidehiko Takigawa, Ryo Yuge, Daisuke Shimizu, Misa Ariyoshi, Rina Otani, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yuichi Hiyama, Yuji Urabe, Akira Ishikawa, Kazuhiro Sentani, Shiro Oka
BACKGROUND: Glutaminase 1 (GLS1), a key enzyme in glutamine metabolism in cancer cells, acts as a tumor promoter and could be a potential therapeutic target. CB-839, a GLS1-specific inhibitor, was developed recently. Herein, we aimed to elucidate the anti-tumor effects and mechanism of action of CB-839 in colorectal cancer (CRC). METHODS: Using the UCSC Xena public database, we evaluated GLS1 expression in various cancers. Immunostaining for GLS1 was performed on 154 surgically resected human CRC specimens...
May 2, 2024: Experimental and Molecular Pathology
https://read.qxmd.com/read/38702621/does-depressurization-of-the-portal-vein-before-liver-transplantation-affect-the-recurrence-of-hcc-a-nested-case-control-study
#27
JOURNAL ARTICLE
Guo Wei, Yong Zhao, Shifeng Feng, Jingsheng Yuan, Gang Xu, Tao Lv, Jian Yang, Lingxiang Kong, Jiayin Yang
BACKGROUND: Portal hypertension (PHT) has been proven to be closely related to the development of hepatocellular carcinoma (HCC). Whether PHT before liver transplantation (LT) will affect the recurrence of HCC is not clear. METHODS: 110 patients with depressurization of the portal vein (DPV) operations (Transjugular Intrahepatic Portosystemic Shunt-TIPS, surgical portosystemic shunt or/and splenectomy) before LT from a HCC LT cohort, matched with 330 preoperative non-DPV patients; this constituted a nested case-control study...
May 3, 2024: BMC Cancer
https://read.qxmd.com/read/38702144/chmp2a-regulates-broad-immune-cell-mediated-antitumor-activity-in-an-immunocompetent-in-vivo-head-and-neck-squamous-cell-carcinoma-model
#28
JOURNAL ARTICLE
Jiyoung Yun, Robert Saddawi-Konefka, Benjamin Goldenson, Riyam Al-Msari, Davide Bernareggi, Jaya L Thangaraj, Shiqi Tang, Sonam H Patel, Sarah M Luna, J Silvio Gutkind, Dan Kaufman
BACKGROUND: Natural killer (NK) cells are key effector cells of antitumor immunity. However, tumors can acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying mechanisms that mediate this resistance enables us to define approaches to improve immune-mediate antitumor activity. In previous studies from our group, a genome-wide CRISPR-Cas9 screen identified Charged Multivesicular Body Protein 2A ( CHMP2A ) as a novel mechanism that mediates tumor intrinsic resistance to NK cell activity...
May 3, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38701539/mesenchymal-stem-cell-derived-exosomes-for-management-of-prostate-cancer-an-updated-view
#29
REVIEW
Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Hafizi, Fatemeh Sadat Mohammadi, Farid Zeynali, Melika Hadad Tehran, Amirreza Rostami
Prostate cancer represents the second most prevalent form of cancer found in males, and stands as the fifth primary contributor to cancer-induced mortality on a global scale. Research has shown that transplanted mesenchymal stem cells (MSCs) can migrate by homing to tumor sites in the body. In prostate cancer, researchers have explored the fact that MSC-based therapies (including genetically modified delivery vehicles or vectors) and MSC-derived exosomes are emerging as attractive options to improve the efficacy and safety of traditional cancer therapies...
May 2, 2024: International Immunopharmacology
https://read.qxmd.com/read/38699640/glp-1-receptor-agonist-as-an-effective-treatment-for-breast-cancer-related-lymphedema-a-case-report
#30
Fionnuala Crowley, Stav Brown, Emily J Gallagher, Joseph H Dayan
INTRODUCTION: Lymphedema is a major public health issue for many women undergoing breast cancer treatment. Although weight loss has been reported to be beneficial in the treatment of lymphedema, no studies to date have examined the use of GLP-1RAs for the treatment of secondary lymphedema. This case report describes a patient who experienced significant resolution of her breast cancer-related lymphedema after initiation of a GLP-1RA for weight loss. MAIN SYMPTOMS AND/OR IMPORTANT CLINICAL FINDINGS: Nine months postoperatively the patient developed arm swelling and disability...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38699337/voriconazole-metabolism-is-associated-with-the-number-of-skin-cancers-per-patient
#31
Jacqueline I Ike, Isabelle T Smith, Dominique Mosley, Christopher Madden, Sarah Grossarth, Briana R Halle, Adam Lewis, Frank Mentch, Hakon Hakonarson, Lisa Bastarache, Lee Wheless
Voriconazole exposure is associated with skin cancer, but it is unknown how the full spectrum of its metabolizer phenotypes impacts this association. We conducted a retrospective cohort study to determine how variation in metabolism of voriconazole as measured by metabolizer status of CYP2C19 is associated with the total number of skin cancers a patient develops and the rate of development of the first skin cancer after treatment. There were 1,739 organ transplant recipients with data on CYP2C19 phenotype. Of these, 134 were exposed to voriconazole...
April 19, 2024: Research Square
https://read.qxmd.com/read/38698870/restoring-ovarian-fertility-and-hormone-function-recent-advancements-ongoing-efforts-and-future-applications
#32
REVIEW
Elizabeth L Tsui, Hannah B McDowell, Monica M Laronda
The last 20 years have seen substantial improvements in fertility and hormone preservation and restoration technologies for a growing number of cancer survivors. However, further advancements are required to fill the gaps for those who cannot use current technologies or to improve the efficacy and longevity of current fertility and hormone restoration technologies. Ovarian tissue cryopreservation (OTC) followed by ovarian tissue transplantation (OTT) offers those unable to undergo ovarian stimulation for egg retrieval and cryopreservation an option that restores both fertility and hormone function...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38698665/anal-dysplasia-and-anal-cancer-screening-practices-among-liver-transplant-centers-in-the-united-states-results-of-an-online-survey
#33
JOURNAL ARTICLE
Eric Moughames, Maaza Abdi, Bridget Morris, Sandy Fang, Joyce Jones, Christine M Durand, Willa Cochran, Eduardo F Ribas, Charlee McLean-Powell, Ahmet Gurakar, Ulrike K Buchwald
BACKGROUND: Solid organ transplant recipients are at an increased risk for anogenital Human Papillomavirus (HPV)-related disease, including anal high-grade squamous intraepithelial lesions (HSIL) and anal squamous cell cancer (ASCC). Guidelines for ASCC screening in transplant recipients are limited. Our aim was to understand current practice of ASCC screening in adult liver transplant (LT) candidates and recipients at transplant centers across the United States. METHODS: We surveyed medical directors of 113 LT centers across the United States which had publicly available contact information...
May 2, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38698266/crl2-klhdc3-and-crl1-fbxw7-cooperatively-mediate-c-myc-degradation
#34
JOURNAL ARTICLE
Saori Motomura, Kanae Yumimoto, Takeshi Tomonaga, Keiichi I Nakayama
c-Myc is a proto-oncoprotein that regulates various cellular processes and whose abnormal expression leads to tumorigenesis. c-Myc protein stability has been shown to be predominantly controlled by the ubiquitin ligase (E3) CRL1Fbxw7 in a manner dependent on glycogen synthase kinase 3 (GSK3)-mediated phosphorylation. Here we show that, in some types of cancer cells, c-Myc degradation is largely insensitive to the GSK3 inhibitor (GSK3i) CHIR99021, suggesting the existence of an E3 other than CRL1Fbxw7 for c-Myc degradation...
May 2, 2024: Oncogene
https://read.qxmd.com/read/38697960/continuously-improving-outcome-over-time-after-second-allogeneic-stem-cell-transplantation-in-relapsed-acute-myeloid-leukemia-an-ebmt-registry-analysis-of-1540-patients
#35
JOURNAL ARTICLE
Ann-Kristin Schmälter, Maud Ngoya, Jacques-Emmanuel Galimard, Ali Bazarbachi, Jürgen Finke, Nicolaus Kröger, Martin Bornhäuser, Matthias Stelljes, Friedrich Stölzel, Johanna Tischer, Thomas Schroeder, Peter Dreger, Igor-Wolfgang Blau, Bipin Savani, Sebastian Giebel, Jordi Esteve, Arnon Nagler, Christoph Schmid, Fabio Ciceri, Mohamad Mohty
Second allogeneic stem cell transplantation (alloSCT2) is among the most effective treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long-term EBMT registry data were used to provide large scale, up-to-date outcome results and to identify factors for improved outcome. Among 1540 recipients of alloSCT2, increasing age, better disease control and performance status before alloSCT2, more use of alternative donors and higher conditioning intensity represented important trends over time...
May 2, 2024: Blood Cancer Journal
https://read.qxmd.com/read/38697731/diagnosis-treatment-and-surveillance-of-diamond-blackfan-anaemia-syndrome-international-consensus-statement
#36
REVIEW
Marcin W Wlodarski, Adrianna Vlachos, Jason E Farrar, Lydie M Da Costa, Antonis Kattamis, Irma Dianzani, Cristina Belendez, Sule Unal, Hannah Tamary, Ramune Pasauliene, Dagmar Pospisilova, Josu de la Fuente, Deena Iskander, Lawrence Wolfe, Johnson M Liu, Akiko Shimamura, Katarzyna Albrecht, Birgitte Lausen, Anne Grete Bechensteen, Ulf Tedgard, Alexander Puzik, Paola Quarello, Ugo Ramenghi, Marije Bartels, Heinz Hengartner, Roula A Farah, Mahasen Al Saleh, Amir Ali Hamidieh, Wan Yang, Etsuro Ito, Hoon Kook, Galina Ovsyannikova, Leo Kager, Pierre-Emmanuel Gleizes, Jean-Hugues Dalle, Brigitte Strahm, Charlotte M Niemeyer, Jeffrey M Lipton, Thierry M Leblanc
Diamond-Blackfan anaemia (DBA), first described over 80 years ago, is a congenital disorder of erythropoiesis with a predilection for birth defects and cancer. Despite scientific advances, this chronic, debilitating, and life-limiting disorder continues to cause a substantial physical, psychological, and financial toll on patients and their families. The highly complex medical needs of affected patients require specialised expertise and multidisciplinary care. However, gaps remain in effectively bridging scientific discoveries to clinical practice and disseminating the latest knowledge and best practices to providers...
May 2024: Lancet Haematology
https://read.qxmd.com/read/38696474/immunomodulation-of-salivary-gland-function-due-to-cancer-therapy
#37
REVIEW
Ana C Costa-da-Silva, Carlos U Villapudua, Matthew P Hoffman, Marit H Aure
Functional salivary glands (SG) are essential for maintaining oral health, and salivary dysfunction is a persistent major clinical challenge. Several cancer therapies also have off-target effects leading to SG dysfunction. Recent advances highlight the role of SG immune populations in homeostasis, dysfunction and gland regeneration. Here, we review what is known about SG immune populations during development and postnatal homeostasis. We summarize recent findings of immune cell involvement in SG dysfunction following cancer treatments such as irradiation (IR) for head and neck cancers, immune transplant leading to graft-versus-host-disease (GVHD) and immune checkpoint inhibitor (ICI) treatment...
May 2, 2024: Oral Diseases
https://read.qxmd.com/read/38695641/blocking-the-atr-serrs-vegfa-pathway-targets-angiogenesis-for-uv-induced-cutaneous-squamous-cell-carcinoma
#38
JOURNAL ARTICLE
Hongyan Lu, Zhangsong Peng, Zhaohui Zheng, Changxing Li, Youyi Wang, Liuping Liang, Yuxiang Chen, Kang Zeng
Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent form of skin cancer, with an escalating incidence rate and a notable potential (up to 5%) for metastasis. Ultraviolet radiation (UVA and UVB) exposure is the primary risk factor for cSCC carcinogenesis, with literature suggesting ultraviolet radiation (UVR) promotes vascular endothelial growth factor A (VEGFA) expression. This study aims to investigate UVR-induced upregulation of VEGFA and explore combination therapeutic strategies. The skin squamous cell carcinoma cell line A431 was exposed to specific durations of ultraviolet radiation...
May 2, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38695148/recent-advances-on-anti-hiv-chimeric-antigen-receptor-t-cell-treatment-to-provide-sustained-hiv-remission
#39
JOURNAL ARTICLE
Hang Su, April Mueller, Harris Goldstein
PURPOSE OF REVIEW: Successful sustained remission of HIV infection has been achieved after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation for treatment of leukemia in a small cohort of people living with HIV (PLWH). This breakthrough demonstrated that the goal of curing HIV was achievable. However, the high morbidity and mortality associated with bone marrow transplantation limits the routine application of this approach and provides a strong rationale for pursuing alternative strategies for sustained long-term antiretroviral therapy (ART)-free HIV remission...
May 2, 2024: Current Opinion in HIV and AIDS
https://read.qxmd.com/read/38694819/the-bone-marrow-of-mouse-rat-chimeras-contains-progenitors-of-multiple-pulmonary-cell-lineages
#40
JOURNAL ARTICLE
Enhong Li, Bingqiang Wen, Dengfeng Gao, Timothy R Kalin, Guolun Wang, Tanya V Kalin, Vladimir V Kalinichenko
Radiation-induced lung injury (RILI) is a common complication of anti-cancer treatments for thoracic and hematologic malignancies. Bone marrow (BM) transplantation restores hematopoietic cell lineages in cancer patients. However, it is ineffective in improving lung repair after RILI due to the paucity of respiratory progenitors in BM transplants. In the present study, we used blastocyst injection to create mouse-rat chimeras, these are artificial animals in which BM is enriched with mouse-derived progenitor cells...
2024: Frontiers in Cell and Developmental Biology
keyword
keyword
74422
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.